rss
J Med Ethics 2008;34:690-694 doi:10.1136/jme.2006.018564
  • Research ethics

Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research

This article has been Unlocked
  1. M Ponder1,
  2. H Statham1,
  3. N Hallowell2,
  4. J A Moon3,
  5. M Richards1,
  6. F L Raymond3
  1. 1
    Centre for Family Research, University of Cambridge, Cambridge, UK
  2. 2
    Public Health Sciences, University of Edinburgh, Edinburgh, UK
  3. 3
    Department of Medical Genetics, Cambridge Institute for Medical Research, Addenbrookes Hospital, Cambridge, UK
  1. Mrs M Ponder, Centre for Family Research, University of Cambridge, Free School Lane, Cambridge CB2 3RF, UK; map1000{at}cam.ac.uk
  • Received 22 August 2006
  • Revised 27 November 2006
  • Accepted 17 December 2006

Abstract

Objectives: To study the consent process experienced by participants who are enrolled in a molecular genetic research study that aims to find new genetic mutations responsible for an apparently inherited disorder.

Design: Semi-structured interviews and analysis/description of main themes.

Participants: 78 members of 52 families who had been recruited to a molecular genetic study.

Results: People were well informed about the goals, risks and benefits of the genetic research study but could not remember the consent process. They had mostly been recruited to take part by trusted clinicians or their relatives but had little memory of, or concern about signing consent forms. Families appeared to regard the research as a continuation of their, or their relatives’, clinical care.

Conclusions: Ethical review should be more flexible in its attitude to consent forms and written information sheets for some sorts of research. For rare genetic disease studies where research has been discussed fully within the clinical setting then the consent obtained at that time could suffice rather than needing extra consent at a later stage. However, clinician-researchers will need to ensure that their duty of care extends for the duration of the research and beyond.

Footnotes

  • Competing interests: MP is Chair of the Genetic Interest Group. FLR is the Principal Investigator for the GOLD study.

  • ↵i The consent form and information sheet for families participating in the research study of the genetics causes of learning disability (GOLD) can be accessed at: http://goldstudy.cimr.cam.ac.uk/consentforms.htm.

  • Ethics approval: The study was approved by the London multi-centre Research Ethics Committee.

Responses to this article

  • Information sheets for research
    • Hugh Davies
    J Med Ethics published online September 10, 2008
This article has been Unlocked

This Article

  1. Free via Creative Commons: CC
  2. Abstract
  3. Full text
  4. PDF

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.